DRUG

cetuximab

3 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for cetuximab

Alzheimer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR Alzheimer's disease 0.277 High partial evidence none

Glioblastoma 2

Mediator Outcome Score Tier Lit. status Trial
EGFR glioblastoma aggressiveness 0.277 High novel signal none
EGFR worse survival 0.277 High reproduces known none

Clinical trials

200 registered trials for cetuximab

Source: ClinicalTrials.gov